{
    "nctId": "NCT01635465",
    "briefTitle": "Vinorelbine Plus Capecitabine Versus Docetaxel Plus Capecitabine in Anthracycline-pretreated Women With Metastatic Breast Cancer",
    "officialTitle": "A Randomised Controlled Phase II Trial of Vinorelbine Plus Capecitabine Versus Docetaxel Plus Capecitabine in Anthracycline-pretreated Women With Metastatic Breast Cancer.",
    "overallStatus": "UNKNOWN",
    "conditions": "Anthracycline-pretreated Metastatic Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 120,
    "primaryOutcomeMeasure": "RECIST 1.1",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* female \u2265 18 years old ECOG 0-2\n\nExclusion Criteria:\n\n* brain metastasis",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}